NEW YORK, May 3- Former drug executive Martin Shkreli, who last year became a lightning rod for outrage over soaring prescription drug prices, may face additional U.S. charges of securities fraud, a federal prosecutor said on Tuesday. Attorney Winston Paes said at a hearing in federal court in Brooklyn, New York. Shkreli, 33, sparked outrage among patients, medical...
Sandy Weill, Citigroup chairman emeritus and former CEO, and his wife Joan discuss their $185 million gift to the University of California, San Francisco for neuroscience research. They believe that this is the decade that neuroscience catches up to other progress in similar sciences. Sandy Weill also weighs in on the financial sector and the prospects for Citigroup.
Scientists say humans have changed the world so dramatically that the planet's biodiversity is on the decline.
Greg Glassman, Crossfit Founder & CEO, talks about his fitness revolution at the iCONIC Conference in Seattle.
Mark Bertolini, Aetna CEO & chairman, discusses how his company is getting employees to improve their sleep, thus improving the company's bottom line. And Bertolini shares his thoughts on Obamacare.
Thomas Panek, Guiding Eyes president & CEO, discusses his organization's partnership with IBM as they attempt to analyze and collect data about its dogs in an effort to perfect the breeding and training process.
Dr. Michael Wu, chief scientist at Lithium Technologies, discusses technology trends from CeBIT in Germany.
Jean-Paul Clozel, CEO of Actelion, says 2015 may be the company's best year, with sales crossing 2 billion Swiss francs thanks to the drug Opsumit.
CNBC's Julia Chatterley reports from Basel on Syngenta and the takeover deal by ChemChina, a Chinese state-owned company.
Severin Schwan, CEO of Roche, discusses his company's full year results, which came in below expectations.
The U.K. is becoming a test bed for developing and proving new digital technologies in health care says George Freeman MP, UK minister for life sciences, as he discusses health tech trends.
Cathrin Petty, head of EMEA healthcare at JP Morgan, says 2016 will be a pivotal year for the health care industry due to new product launches and approvals, as well as commercial headwinds.
Karl-Ludwig Kley, chairman and CEO of Merck, is positive about the prospects for the health care and life sciences sector.
Feike Sijbesma, CEO of DSM, says the industry is changing the world transitions from fossil fuels to bio-renewable energy and discusses the economy in Europe and China.
Harrison Wang, China spokesperson of Vitality Air, explains the concept behind the Canada-based company which sells cans of clean air.
Johnson & Johnson has begun clinical trials for an Ebola vaccine in Sierra Leone.
China's much-hyped market for vitamins and supplements is facing a steep challenge from traditional remedies from ginseng to deer antler.
A U.S. appeals court cancelled EPA approval of an insecticide developed by Dow AgroSciences.
A toxic algae found off the west coast could threaten marine economy for years.
A new study confirmed something researchers have suspected for decades: The stars that populate our universe are burning themselves out.